Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3040562	pd-diffi	— (—)	115	940	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Dialysis

114

+∞

120.42

8.2

0.0

—

Nephropathy related operations

114

+∞

119.22

8.2

0.0

—

Dialysis, with operation codes

114

+∞

119.19

8.2

0.0

—

Chronic kidney disease

114

+∞

118.00

8.2

0.0

—

Care involving dialysis

110

+∞

115.28

8.4

0.0

—

Renal failure

114

+∞

113.30

8.2

0.0

—

Other dialysis

104

+∞

110.25

8.8

0.0

—

All chronic kidney diseases

114

+∞

109.82

8.2

0.0

—

L04AA Selective immunosuppressants

59.33

105.37

8.2

6.8

—

ILD medications: immunosuppressive drugs

22.13

89.23

8.1

7.9

—

Acute peritonitis

+∞

84.85

10.6

0.0

—

Glomerular diseases

113.77

83.05

8.2

12.3

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

21.53

75.16

7.9

9.9

—

Insulin, fast-acting

18.66

68.17

10.3

8.8

—

Heart failure, not strict

96.37

67.34

9.0

6.2

—

Insulin, fast-acting or short human

18.04

67.11

10.3

9.1

—

Glomerular disorders in diseases classified elsewhere

105.87

67.01

9.0

13.7

—

Other bacterial diseases

15.70

62.91

9.3

8.2

—

Insulin, combination of fast acting with intermediate-acting or long-acting

14.34

60.87

10.1

7.9

—

L04AD Calcineurin inhibitors

129.80

59.97

7.8

11.8

—

Type 1 diabetes

24.75

59.40

10.6

8.9

—

Insulin medication

14.37

57.91

10.1

8.0

—

Insulin, intermediate and long-acting

14.46

56.82

10.5

8.2

—

Septicaemia

19.59

56.77

9.6

7.9

—

Explicit Sepsis

18.31

56.27

9.4

8.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

11.78

55.66

7.5

8.8

—

Other septicaemia

19.73

54.19

9.7

6.8

—

Secondary hypertension

+∞

54.04

9.4

0.0

—

Type 1 diabetes, wide definition

22.99

53.62

11.1

8.9

—

Bacterial infection, other or unspecified

18.62

51.69

9.8

9.1

—

Bacterial infection, other or unspecified

17.70

50.82

9.8

9.7

—

Sub-endpoint used in defining T1D endpoints

16.31

50.34

10.4

9.6

—

Other bacterial diseases

11.97

50.22

8.9

7.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

12.24

49.57

8.1

8.4

—

Diabetic nephropathy

67.08

46.84

10.4

7.6

—

Peripheral artery disease

17.54

46.50

10.5

8.9

—

Diabetic nephropathy, excluding more controls

74.71

44.79

10.4

5.8

—

Diseases of arteries, arterioles and capillaries

13.00

44.61

10.1

9.7

—

Disorders of other endocrine glands

13.35

44.16

6.9

9.1

—

Hypertensive diseases

59.34

44.16

7.8

7.2

—

Hypertension

59.33

44.16

7.8

7.2

—

ILD medications

11.19

43.78

8.6

8.4

—

Atherosclerosis, excluding cerebral and coronary sclerosis

18.66

43.19

10.1

8.1

—

Metabolic disorders

12.00

42.35

8.8

6.2

—

Aplastic and other anaemias

12.76

40.74

7.0

9.9

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

10.24

40.56

9.5

7.2

—

First line medication for Crohn's disease

9.38

35.47

8.1

8.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

8.47

34.91

8.4

7.4

—

Persons encountering health services in other circumstances, wide

9.09

34.34

9.5

7.2

—

Implicit Sepsis

10.38

34.28

8.8

9.1

—

All-cause Heart Failure

11.87

34.03

9.6

9.1

—

Heart failure, strict

11.40

33.27

9.6

9.3

—

Other disorders of kidney and ureter

56.09

33.22

7.8

9.4

—

Heart failure,strict

59.37

32.16

9.6

7.2

—

Other retinal disorders

8.54

32.00

9.9

9.7

—

Statin medication

16.08

32.00

7.7

6.6

—

Bacterial Sepsis

11.41

31.87

9.8

8.9

—

Other disorders of fluid, electrolyte and acid-base balance

51.80

31.49

8.0

10.4

—

Implicit bacterial Sepsis

12.91

31.06

10.2

8.7

—

Hypertension, essential

43.45

30.99

10.0

7.2

—

Heart failure and coronary heart disease

13.79

30.68

10.9

7.8

—

Other disorders of skin and subcutaneous tissue

8.30

30.51

11.0

7.8

—

Intestinal infectious diseases

6.82

30.50

9.2

7.3

—

Diabetic retinopathy

11.90

30.01

9.7

8.9

—

Implicit Sepsis

8.98

29.99

9.0

8.9

—

Disorders of choroid and retina

7.76

29.68

9.6

9.4

—

Implicit bacterial Sepsis

12.03

29.39

10.2

9.7

—

Coronary atherosclerosis

14.77

29.38

10.1

7.9

—

Acute renal failure

+∞

29.17

9.3

0.0

—

Erysipelas

11.80

28.78

9.9

9.7

—

Erysipelas

12.65

28.75

10.6

10.1

—

Type 2 diabetes, wide definition

9.18

28.26

11.1

8.6

—

Endocrine, nutritional and metabolic diseases

18.24

27.86

9.6

5.3

—

Disorders of lens

9.85

27.73

8.5

11.0

—

Glomerulonephritis

42.79

27.71

5.2

8.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

8.24

27.37

9.1

7.9

—

Ischemic heart diseases

9.23

27.32

9.8

5.5

—

Heart failure and antihypertensive medication

+∞

27.21

11.2

0.0

—

Amputation

62.39

26.94

12.4

5.4

—

Coronary revascularization (ANGIO or CABG)

9.30

26.48

11.0

5.6

—

Autoimmune diseases excluding thyroid diseases, strict definition

8.31

26.45

9.2

6.8

—

Other and unspecified anaemias

10.22

26.21

8.3

9.7

—

Other anaemias

10.19

26.13

8.3

9.7

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

7.23

25.85

9.4

7.3

—

GASTRO-related operations

+∞

25.72

9.8

0.0

—

Any gastric operation

+∞

25.72

9.8

0.0

—

Type 1 diabetes, wide definition, subgroup 1

21.81

25.55

10.9

8.9

—

Percutaneous Coronary Intervention

9.09

25.48

10.8

5.6

—

Condition for Implicit Sepsis (Organ dysfunction codes)

7.82

25.45

8.6

—

Autoimmune diseases excluding thyroid diseases

7.77

25.25

9.5

6.9

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

+∞

25.17

10.3

0.0

—

7.57

25.14

9.8

7.6

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

7.57

25.14

9.8

7.6

—

Other heart diseases, wide

7.44

24.95

9.2

7.2

—

Diabetic retinopathy, strict definition

25.87

24.59

10.8

10.7

—

Diabetes, varying definitions

6.87

24.49

9.1

7.1

—

Diabetes mellitus

6.85

24.39

9.1

7.1

—

Ischaemic heart disease, wide definition

9.06

24.31

9.8

10.0

—

Diabetes, insulin treatment (Kela reimbursement)

6.59

24.07

9.4

7.1

—

Unspecified kidney failure

+∞

23.97

5.0

0.0

—

Ulcer of lower limb, not elsewhere classified

37.69

23.90

11.4

10.9

—

Infections of the skin and subcutaneous tissue

6.79

23.82

8.4

8.3

—

Dental caries

28.02

23.54

8.0

10.1

—

Emergency coronary revascularization (for ACS)

7.51

23.40

10.9

6.0

—

Disorders of parathyroid gland

35.91

22.81

7.1

7.3

—

Major coronary heart disease event

7.50

22.73

10.7

6.2

—

Caries of dentine

38.95

22.32

8.7

15.1

—

Autoimmune diseases

7.09

22.26

8.4

6.9

—

Hyperparathyroidism

34.71

21.89

7.4

7.3

—

Insulin, fast-acting (human)

29.11

21.82

11.4

12.3

—

All pneumoniae

5.46

21.80

10.2

6.6

—

Bleeding

6.00

21.51

9.1

8.8

—

Complications of surgical and medical care, not elsewhere classified

5.55

21.49

8.3

9.0

—

Disorders of lipoprotein metabolism and other lipidaemias

9.29

21.46

10.7

7.0

—

Pneumonia, organism unspecified

5.82

21.27

10.6

6.5

—

Certain infectious and parasitic diseases

10.31

21.19

9.2

7.2

—

Diabetic retinopathy, excluding more controls

27.29

21.02

8.9

5.1

—

Diabetes medication

6.07

20.88

9.3

7.1

—

Pneumonias (Asthma/COPD co-morbidities)

5.28

20.73

10.1

6.7

—

Hard cardiovascular diseases

7.05

20.52

10.6

6.8

—

Type 2 diabetes

6.87

20.42

10.0

8.3

—

Used for control exclusion in common control thyroid runs

7.08

20.24

8.6

6.9

—

Covid-19 confirmed case

8.40

20.11

8.9

8.0

—

Diabetic maculopathy, excluding more controls

31.40

19.23

10.8

11.5

—

Influenza and pneumonia

4.98

18.70

10.4

6.6

—

Peripheral arterial reconstruction

30.08

18.30

10.7

7.0

—

Senile cataract

8.89

18.23

8.7

13.1

—

Other cataract

9.02

17.81

8.2

12.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4.80

17.72

10.4

7.1

—

Codes for special purposes

6.12

17.57

8.4

8.0

—

Provisional assignment of new diseases of uncertain etiology

6.12

17.57

8.4

8.0

—

ILD medications: azathioprine

42.08

17.26

6.6

7.6

—

Presence of other functional implants

9.80

17.20

8.7

10.5

—

Vitreous haemorrhage

25.68

16.88

10.1

6.4

—

Diabetic maculopathy

19.71

16.70

10.8

10.7

—

Polyarthropathies

5.60

16.31

10.9

7.9

—

Fever of other and unknown origin

6.01

15.99

9.4

7.5

—

Diarrhoea and gastroenteritis of presumed infectious origin

4.74

15.76

8.7

7.6

—

Any reimbursement code in KELA

+∞

15.58

9.6

0.0

—

Intestinal infectious diseases

4.43

15.14

9.8

7.5

—

Complications of medical and surgical care

4.89

14.89

8.8

8.4

—

Dermatitis

5.47

14.66

7.9

8.8

—

Complications of procedures, not elsewhere classified

4.97

14.58

10.0

9.3

—

Hernia of abdominal wall, postoperative

+∞

14.58

12.1

0.0

—

Cerebrovascular diseases (FINNGEN)

+∞

14.52

7.2

0.0

—

Major coronary heart disease event excluding revascularizations

7.62

14.21

8.7

8.1

—

Azathioprine

19.14

14.20

6.6

5.8

—

Atrial fibrillation and flutter

+∞

13.99

9.8

0.0

—

Implicit viral Sepsis

15.74

13.89

8.0

6.5

—

Cardiac arrhythmias

8.41

13.78

8.2

5.2

—

Gout, FINNGEN

11.99

13.52

9.6

9.8

—

Implicit viral Sepsis

21.15

13.31

7.3

5.7

—

Viral Sepsis

21.15

13.31

7.3

5.7

—

Gout, idiopatic and unspecified

13.77

13.20

9.8

12.3

—

Nutritional anaemias

5.79

13.16

10.8

7.9

—

Inflammatory bowel disease treatment related agents

3.93

13.09

6.8

9.1

—

Disorders of vitreous body

5.66

12.87

9.7

8.7

—

Gout

11.13

12.74

9.6

11.2

—

Chronic apical periodontitis

3.99

12.52

9.4

7.5

—

Hypertensive Renal Disease

+∞

12.51

7.6

0.0

—

Disorders of vitreous body and globe

5.49

12.46

9.7

8.5

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.20

12.43

10.1

7.0

—

Hyperlipidaemia, other/unspecified

13.82

12.42

13.6

9.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.03

12.42

9.8

7.1

—

Dermatitis and eczema

3.77

12.08

8.9

8.0

—

Tramadol

4.88

12.00

8.5

7.5

—

Gout, unspecified

13.36

11.91

10.7

12.1

—

Hypothyroidism, strict autoimmune

6.07

11.78

7.6

7.7

—

Other and unspecified dermatitis

5.37

11.32

7.7

8.4

—

Acute upper respiratory infections of multiple and unspecified sites

4.45

11.30

7.3

7.7

—

STROKE

16.15

11.05

8.8

6.8

—

Diseases of the skin and subcutaneous tissue

4.60

10.98

8.9

6.3

—

Certain disorders involving the immune mechanism

11.90

10.81

8.1

10.1

—

General examination and investigation of persons without complaint and reported diagnosis

5.22

10.76

6.8

9.2

—

Myocardial infarction

11.36

10.75

9.3

8.4

—

Osteopathies and chondropathies

4.76

10.57

9.5

8.5

—

Other CVD (FINNGEN)

+∞

10.37

6.0

0.0

—

COPD/asthma/ILD related infections

4.45

10.30

8.4

7.6

—

COPD/asthma related infections

4.45

10.30

8.4

7.6

—

Fitting and adjustment of other devices

+∞

10.01

5.2

0.0

—

Fluid overload

+∞

9.50

10.2

0.0

—

Heart failure and bmi 25plus

9.65

9.44

9.8

10.2

—

Bronchitis

3.49

9.43

8.3

8.4

—

Charcot foot

+∞

9.39

13.3

0.0

—

Adjustment and management of implanted device

+∞

9.37

10.4

0.0

—

Iron deficiency anaemia

7.00

9.36

10.6

8.0

—

Osteomyelitis

21.76

9.34

10.8

5.0

—

3.65

9.31

9.6

7.9

—

Non-rheumatic valve diseases

9.02

9.28

8.3

8.5

—

Valvular heart disease excluding rheumatic fever

7.98

9.11

8.9

7.5

—

Nausea and vomiting

9.29

9.11

6.9

—

Viral and other specified intestinal infections

9.26

9.09

7.2

9.2

—

Gout, strict definition

11.45

9.05

9.0

10.8

—

Viral and other specified intestinal infections

8.34

9.02

6.9

8.7

—

Myocardial infarction, without ST-elevation

5.09

8.98

7.7

10.7

—

Second line medication for Crohn's disease

4.00

8.76

6.6

8.6

—

L04AX Other immunosuppressants

4.00

8.76

6.6

8.6

—

Other acute lower respiratory infections

4.14

8.65

9.4

8.0

—

Cutaneous abscess, furuncle and carbuncle

7.61

8.62

10.1

10.3

—

Factors influencing health status and contact with health services

+∞

8.58

7.0

0.0

—

Gastrointestinal diseases

16.03

8.52

7.5

1.6

—

Oral corticosteroids

3.35

8.51

8.5

8.9

—

Abdominal and pelvic pain

3.60

8.34

8.2

9.9

—

Acute upper respiratory infections

3.39

8.27

9.1

8.0

—

Myocardial infarction, strict

9.32

8.08

10.0

8.4

—

Any death

4.00

7.91

9.0

10.5

—

Other disorders of glucose regulation and pancreatic internal secretion

11.85

7.57

13.5

6.5

—

Other CVD

11.83

7.56

7.1

9.4

—

Abnormalities of breathing

3.34

7.47

7.9

—

Angina pectoris

8.10

7.41

9.8

8.4

—

Certain infectious and parasitic diseases

6.08

7.34

10.8

7.5

—

Failure and rejection of transplanted organs and tissues

+∞

7.31

3.3

0.0

—

Tubulo-interstitial nephritis, not specified as acute or chronic

+∞

7.29

11.0

0.0

—

Hydronephrosis

+∞

7.29

4.4

0.0

—

Cellulitis

6.81

7.27

6.2

9.5

—

Symptoms and signs involving the digestive system and abdomen

3.38

7.21

8.1

9.9

—

Hypotension

12.01

7.07

7.3

6.4

—

Persons encountering health services in other circumstances

9.95

6.99

11.8

7.4

—

Other special examinations and investigations of persons without complaint or reported diagnosis

4.16

6.97

9.7

9.2

—

Exposure to unspecified factor

2.90

6.84

12.2

6.6

—

Other problems related to primary support group, including family circumstances

13.40

6.77

2.3

4.3

—

Non-ischemic cardiomyopathy

12.08

6.75

9.5

11.9

—

General symptoms and signs

3.14

6.73

9.1

6.8

—

Diseases of the digestive system

3.98

6.56

7.9

9.2

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

4.00

6.54

8.7

10.2

—

Iron deficiency anaemia secondary to blood loss (chronic)

10.01

6.52

10.1

5.5

—

Medical observation and evaluation for suspected diseases and conditions

4.02

6.45

8.4

9.2

—

Other pulmonary diagnosis

4.36

6.36

11.4

7.8

—

Excluding asthma or asthma-COPD overlap

4.36

6.36

10.5

7.8

—

COPD differential diagnosis

4.36

6.36

10.5

7.8

—

ILD differential diagnosis

4.36

6.36

10.5

7.8

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

7.29

6.34

3.9

8.7

—

Fitting and adjustment of external prosthetic device

+∞

6.30

13.7

0.0

—

Viral pneumonia

11.02

6.29

11.2

6.5

—

Microscopic polyangiitis

+∞

6.28

1.5

0.0

—

Explicit bacterial Sepsis

18.02

6.26

9.2

5.6

—

Special screening examination for other diseases and disorders

18.01

6.26

5.8

8.2

—

Chronic tubulo-interstitial nephritis

+∞

6.25

14.0

0.0

—

Hypothyroidism, other/unspecified

3.12

6.17

7.9

8.5

—

Atrial fibrillation and flutter with reimbursement

+∞

6.07

12.1

0.0

—

Oedema, not elsewhere classified

6.58

5.96

11.1

8.5

—

Dyspnoea

2.98

5.95

7.6

9.0

—

Sulfonylureas

6.29

5.92

7.3

8.4

—

Invasive ventilation

15.03

5.90

7.8

5.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

3.00

5.83

7.9

8.5

—

Other functional intestinal disorders

4.01

5.79

8.8

7.2

—

Acute bronchitis

3.92

5.71

9.7

7.5

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

3.07

5.65

8.1

8.5

—

Hypoglycaemia, other or unspecified

10.03

5.53

10.7

3.7

—

Other local infections of skin and subcutaneous tissue

10.02

5.52

7.8

7.7

—

Other bacterial intestinal infections

10.01

5.52

13.9

5.2

—

Pure hypercholesterolaemia

5.50

5.51

8.6

7.6

—

Conduction disorders

8.92

5.46

7.9

6.6

—

Abnormal findings on examination of urine, without diagnosis

16.07

5.41

10.3

5.6

—

Enterocolitis due to Clostridium difficile

16.03

5.41

14.0

5.6

—

Opioids

3.07

5.40

9.5

6.9

—

Hernia of abdominal wall

3.72

5.36

10.9

9.4

—

Other bacterial intestinal infections

7.86

5.33

15.6

6.8

—

Unspecified contracted kidney

+∞

5.23

8.2

0.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3.20

5.22

9.9

8.8

—

Unspecified haematuria

3.79

5.21

9.8

7.7

—

Pain in limb

2.85

5.21

9.4

7.9

—

Diseases of the eye and adnexa

3.51

5.20

6.5

10.0

—

Autoimmune diseases related-to ILD

2.75

5.20

5.9

9.4

—

Other diseases of intestines

2.60

5.19

8.1

7.4

—

Streptococcal septicaemia

13.36

5.07

10.1

5.0

—

Cerebrovascular diseases

2.99

5.07

6.7

9.6

—

Presence of cardiac and vascular implants and grafts

6.04

5.01

9.5

10.7

—

Other diseases of hard tissues of teeth

5.54

4.96

2.9

8.4

—

Other disorders of urethra and urinary system

3.21

4.96

9.5

7.9

—

Diseases of oesophagus, stomach and duodenum

2.54

4.90

10.8

7.4

—

Asthma, excluding more controls

4.35

4.87

6.9

9.2

—

AV-block

9.86

4.86

7.9

—

Other (not insulin) diabetes medications

3.30

4.85

8.1

8.3

—

Diseases of pulp and periapical tissues, including avohilmo

2.68

4.85

9.4

6.2

—

Symptoms and signs involving the circulatory and respiratory systems

2.69

4.82

9.6

7.9

—

Other and unspecified local infections of skin and subcutaneous tissue

9.02

4.78

8.1

7.7

—

Dental operations

4.28

4.77

9.3

4.6

—

Other specified/unspecified arthritis

5.72

4.74

10.5

9.0

—

All influenza

5.72

4.74

8.8

7.0

—

Disorders of skin appendages

3.40

4.73

11.5

7.9

—

Pacemaker

5.19

4.72

8.5

7.9

—

Malaise and fatigue

3.66

4.64

8.6

7.9

—

Other disorders of optic [2nd] nerve and visual pathways

14.03

4.57

6.4

4.8

—

Chronic periodontitis, including avohilmo

2.58

4.57

7.4

9.5

—

Periodontitis

2.58

4.55

7.4

9.5

—

Persons with potential health hazards related to communicable diseases

3.31

4.52

5.6

8.9

—

Idiopathic gout

10.02

4.52

10.1

10.4

—

Other diseases of intestine

10.01

4.51

7.0

8.6

—

Codeine

2.91

4.49

8.4

7.1

—

Systemic connective tissue disorders

4.82

4.49

4.2

9.0

—

Bacterial intestinal infections, IBD co-morbidities

6.67

4.46

13.9

6.0

—

Disorders of the thyroid gland

2.60

4.44

8.0

8.5

—

Diabetic neuropathy

5.20

4.43

11.7

8.9

—

Obesity due to excess calories

3.20

4.32

10.4

7.1

—

Operations 2 for CAVS

5.61

4.32

6.0

11.4

—

Calcific aortic valvular stenosis, diagnosis (helper)

5.61

4.32

6.0

11.4

—

Calcific aortic valvular stenosis, including rheumatic fever

5.61

4.31

6.0

11.4

—

Other arthritis (FG)

5.00

4.31

10.5

8.9

—

Sequelae with surgical and medical care as external cause

5.51

4.28

11.4

8.1

—

Abnormal results of function studies

11.69

4.27

10.1

3.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6.90

4.27

6.7

9.7

—

Other nutritional deficiencies

2.77

4.19

10.2

8.4

—

Sequelae of external causes of morbidity and mortality

4.80

4.17

10.8

8.1

—

Bacterial pneumonia, not elsewhere classified

4.40

4.09

9.9

7.6

—

Oxycodone

4.72

4.06

10.9

6.7

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

8.01

4.06

4.6

9.4

—

Calcific aortic valvular stenosis

5.08

4.02

6.0

10.5

—

Calcific aortic valvular stenosis, operated

5.08

4.02

6.0

10.5

—

Viral pneumonia (unknown virus, not influenza)

10.02

4.01

11.0

9.0

—

Trigger finger

10.01

4.01

15.4

12.4

—

Umbilical hernia

5.00

3.99

9.7

8.5

—

Bacterial pneumoniae

4.25

3.97

9.9

7.7

—

Diseases of oral cavity, salivary glands and jaws

4.78

3.94

4.4

8.4

—

Type 1 diabetes, strict (exclude DM2)

7.26

3.85

4.4

8.7

—

Type 1 diabetes, definitions combined

7.26

3.85

4.4

8.7

—

Use of pramipexole

6.00

3.81

9.1

9.9

—

Disorders of optic nerve and visual pathways

8.76

3.77

6.4

4.1

—

Cardiomyopathy

8.76

3.77

11.7

5.4

—

Other follicular disorders

12.02

3.76

9.5

3.6

—

Other and unspecified iron deficiency

4.58

3.73

11.2

7.1

—

Symptoms and signs involving the urinary system

2.58

3.71

10.4

7.8

—

Asthma

3.42

3.70

6.9

7.8

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

6.67

3.67

12.3

7.3

—

Acute sinusitis

3.16

3.66

9.5

6.9

—

Diseases of pulp and periapical tissues and dental caries

3.11

3.65

8.3

4.6

—

Asthma (only as main-diagnosis), excluding more controls

4.13

3.59

7.5

9.2

—

Gingivitis and periodontal diseases

2.40

3.58

8.3

8.7

—

Chronic periodontitis, complicated

2.83

3.56

9.0

8.8

—

Examination and observation for other reasons

3.21

3.53

7.7

9.5

—

Other and unspecified tonsillitis

4.40

3.52

11.0

8.4

—

Disorders of sclera, cornea, iris and ciliary body

2.70

3.48

4.9

9.0

—

Missing teeth due to accident, extraction or parodontitis

2.79

3.44

8.6

8.8

—

Viral infections characterized by skin and mucous membrane lesions

2.98

3.40

6.1

7.8

—

Diseases of the ear and mastoid process

2.21

3.34

7.9

8.3

—

Myocardial infarction, with ST-elevation

5.72

3.34

11.0

10.4

—

Disorders of gallbladder, biliary tract and pancreas

2.28

3.31

6.3

9.5

—

Congenital malformations of the urinary system

8.59

3.26

3.5

4.0

—

Congenital malformations of the urinary system

8.59

3.26

3.5

4.0

—

Benign neoplasm of other and unspecified endocrine glands

8.58

3.26

3.2

9.3

—

Misadventures to patients during surgical and medical care

8.58

3.26

5.0

10.6

—

Other and unspecified polyneuropathies, also in other diseases

4.74

3.23

14.8

8.4

—

Other respiratory disorders and diseases

4.74

3.23

15.4

8.5

—

Other diseases of the respiratory system

4.74

3.23

15.4

8.5

—

Gastroduodenal ulcer

4.73

3.22

8.4

9.7

—

Mood disorders, excluding more controls

2.31

3.22

7.5

8.7

—

Bacterial, viral and other infectious agents

5.34

3.19

10.1

7.1

—

Other skin changes

5.34

3.19

6.5

5.8

—

Open wound of ankle and foot

6.37

3.18

9.9

6.3

—

Other endocrine disorders

8.23

3.17

5.5

2.7

—

Asthma (only as main-diagnosis)

3.27

3.15

7.5

7.8

—

Arthropathies

2.38

3.13

9.2

7.2

—

Stroke, including SAH

2.56

3.13

7.6

9.9

—

Benign neoplasm: Colon, unspecified

4.50

3.11

7.9

7.6

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

3.43

3.10

10.0

9.2

—

Fracture of lower leg, including ankle

2.70

3.08

13.9

7.9

—

Depression

2.23

3.08

7.5

8.7

—

Sarcoidosis

7.51

3.05

11.0

9.5

—

Bacterial pneumonia (organism specified)

2.95

3.05

9.9

8.8

—

Neoplasms

2.42

3.01

10.4

7.8

—

Other diseases of the digestive system

3.55

2.98

7.9

9.3

—

GI-bleeding

3.55

2.98

7.9

9.3

—

Other complications of surgical and medical care, not elsewhere classified

10.01

2.98

8.4

3.0

—

Sensorineural hearing loss

2.43

2.95

7.5

9.7

—

Abnormal findings on diagnostic imaging of lung

2.83

2.89

7.8

9.4

—

Injuries to the ankle and foot

2.28

2.88

10.1

7.5

—

Other diseases of pleura

2.73

2.87

11.9

8.4

—

Other blood glucose lowering drugs, excl. Insulins

5.39

2.86

13.6

6.0

—

Other soft tissue disorders, not elsewhere classified

2.16

2.80

9.3

7.6

—

Hernia

2.17

2.80

10.1

7.9

—

Psychiatric diseases

2.16

2.78

7.4

8.6

—

Erosion of teeth , including avohilmo

3.57

2.78

12.4

9.6

—

Keratitis

3.08

2.76

4.5

9.6

—

Impotence

8.35

2.75

8.8

7.8

—

Pain (limb, back, neck, head abdominally)

2.44

2.74

9.7

—

Bacterial, viral and other infectious agents

5.01

2.72

11.3

6.5

—

Aortic valve malfunction, age under 60 years

5.01

2.72

8.1

11.1

—

Finngen Rheumatological endpoints

2.18

2.72

7.3

8.4

—

Abnormal findings on examination of blood, without diagnosis

2.62

2.71

7.3

9.7

—

Stroke, excluding SAH

2.43

2.70

8.0

9.5

—

Other or unspecified ileus, impaction or obstruction

6.00

2.69

10.8

10.5

—

Parasetamol

2.41

2.68

9.8

8.3

—

Superficial injury of lower leg

4.21

2.67

9.1

7.9

—

Polyneuropathies and other disorders of the peripheral nervous system

3.75

2.67

14.8

8.7

—

Conductive and sensorineural hearing loss

2.29

2.62

7.5

9.4

—

Coagulation defects, purpura and other haemorrhagic conditions

4.67

2.59

4.6

9.3

—

Ventral hernia

4.67

2.59

11.4

7.5

—

Dental caries, including avohilmo

2.42

2.59

7.8

5.3

—

Obesity

2.37

2.58

10.4

8.5

—

Obesity and other hyperalimentation

2.37

2.57

10.4

8.5

—

Mycoses

3.60

2.57

10.9

8.9

—

Pleural effusion

5.46

2.54

7.3

6.0

—

All influenza (not pneumonia)

5.46

2.54

7.5

6.4

—

Mood [affective] disorders

2.05

2.53

7.5

8.6

—

Mood disorders

2.04

2.52

7.5

8.6

—

Nonsuppurative otitis media

3.54

2.48

3.8

8.8

—

Constipation

2.09

2.48

9.8

7.9

—

Fracture of foot, except ankle

3.46

2.48

12.0

9.2

—

Gonarthrosis, primary, with knee surgery

0.00

2.44

0.0

9.6

—

Other reaction to severe stress, and adjustment disorders

2.90

2.41

7.1

9.5

—

Seborrhoeic keratosis

5.00

2.40

12.7

6.1

—

Caries of dentine, including avohilmo

2.26

2.38

9.0

5.2

—

Diagnoses used for exclusion with ILD

3.64

2.36

11.1

8.7

—

Type of accident

3.03

2.35

9.6

9.4

—

Sleep apnoea

2.03

2.31

9.5

8.3

—

Atopic dermatitis, strict definition with reimbursement

3.22

2.29

10.8

9.1

—

Other diseases of urinary system

2.02

2.29

9.1

7.8

—

Other maternal disorders predominantly related to pregnancy

3.13

2.28

7.3

5.3

—

Acute appendicitis

2.18

2.27

9.1

8.5

—

Asthma (mode)

2.79

2.27

6.3

7.8

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

3.89

2.25

8.1

10.2

—

Anxiety disorders, excluding more controls

2.13

2.24

9.2

8.5

—

Type 2 diabetes, strict (exclude DM1)

2.49

2.23

7.9

8.5

—

Type 2 diabetes, definitions combined

2.49

2.23

7.9

8.5

—

Neurological diseases

2.05

2.21

10.3

6.5

—

Acne

5.55

2.21

21.2

2.7

—

Type 1 diabetes, strict definition, subgroup 1

5.55

2.21

3.4

8.4

—

Type 1 diabetes, strict definition

5.55

2.21

3.4

8.4

—

Asthma, unspecified (mode), excluding more controls

3.52

2.20

8.1

9.5

—

Type 2 diabetes, definitions combined, including avohilmo

2.47

2.19

7.9

8.5

—

COPD (mode)

3.93

2.19

13.1

8.6

—

Diseases of the musculoskeletal system and connective tissue

2.51

2.16

5.5

7.0

—

Corneal ulcer

3.69

2.15

4.0

10.1

—

Paralytic ileus and intestinal obstruction

3.68

2.14

9.6

8.4

—

Fracture of shoulder and upper arm

2.62

2.13

13.6

8.6

—

Ischaemic Stroke, excluding all haemorrhages

2.28

2.13

7.3

9.5

—

Codeine or tramadol medication

1.90

2.12

8.2

9.3

—

Haemorrhage from respiratory passages

3.01

2.12

9.4

8.0

—

Fall on same level

1.84

2.10

12.9

6.6

—

In situ neoplasms

3.20

2.09

3.1

8.5

—

Disorders of continuity of bone

5.00

2.07

8.0

5.1

—

Valvular operations

5.00

2.07

9.0

4.8

—

Presence of other devices

4.98

2.06

2.8

11.1

—

Pain, not elsewhere classified

3.50

2.05

5.9

9.2

—

Myocardial infarction, unclassifiable

4.12

2.05

13.0

8.5

—

Reimbursement for rheumatic diseases

2.25

2.05

3.9

8.9

—

Other/unspecified dorsalgia

2.68

2.04

13.3

9.1

—

Appendicitis, broad definition

2.08

2.04

9.1

8.6

—

Benign neoplasm of colon, rectum, anus and anal canal

2.25

2.01

7.0

9.7

—

Cough

2.84

2.00

9.4

6.5

—

Diseases of liver

2.63

2.00

7.5

9.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

2.63

2.00

8.0

7.7

—

Inguinal hernia

2.23

1.99

8.5

—

Exclusions for E4_PCOS_BROAD

3.33

1.96

7.6

6.9

—

Diseases of appendix

2.04

1.96

9.1

8.5

—

Atopic dermatitis, strict definition

2.76

1.94

10.8

6.3

—

Later onset COPD, excluding more controls

4.83

1.94

12.2

9.4

—

Leisure time condition

3.75

1.93

14.0

7.2

—

Other viral diseases

2.56

1.93

6.1

9.2

—

Diseases of middle ear and mastoid

2.15

1.93

8.0

8.2

—

Injuries to the knee and lower leg

1.80

1.92

10.3

7.4

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

4.48

1.91

4.4

5.2

—

External causes of morbidity and mortality

2.34

1.91

7.6

6.8

—

Chronic lower respiratory diseases

1.75

1.89

7.8

8.3

—

Otitis externa

3.18

1.88

12.4

7.6

—

Other diseases of anus and rectum

3.18

1.87

5.6

9.1

—

Other diseases of liver

3.53

1.83

9.0

9.2

—

Viral warts

4.17

1.82

6.2

6.7

—

Irregular menses

2.87

1.81

8.3

6.9

—

Type1 diabetes, definitions combined, early onset

4.15

1.81

4.4

6.7

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2.32

1.81

11.4

7.7

—

Exposure to other specified factors

1.92

1.78

10.4

7.8

—

Persons encountering health services for examination and investigation

2.33

1.77

9.6

9.2

—

Acute appendicitis, with complications

3.33

1.74

8.5

10.8

—

Cervicobrachial syndrome

3.33

1.74

8.7

9.2

—

Viral infections characterized by skin and mucous membrane lesions

1.84

1.73

6.3

8.7

—

Cardiodefibrillation

2.49

1.73

6.3

9.3

—

Open wound of lower leg

3.85

1.71

6.0

8.0

—

Asthma, unspecified (mode)

2.74

1.71

8.1

8.0

—

Unstable angina pectoris

3.38

1.71

4.0

9.4

—

Diverticular disease of intestine

2.08

1.71

7.7

8.3

—

Polycystic ovarian syndrome, consortium definition

2.41

1.68

9.6

7.0

—

Asthma, hospital admission 2, infections

2.05

1.66

6.6

8.4

—

Asthma-related infections

2.05

1.66

6.6

8.4

—

Anxiety disorders

1.83

1.66

8.8

8.0

—

Asthma-related pneumonia

2.50

1.66

6.9

8.7

—

Asthma, hospital admissions 3, pneumonia

2.50

1.66

6.9

8.7

—

Asthma-related pneumonia or sepsis

2.50

1.66

6.9

8.7

—

Disorders of synovium and tendon

2.19

1.64

10.8

8.8

—

Injuries to the thorax

2.24

1.63

14.9

9.3

—

Substance abuse, excluding more controls

2.18

1.61

8.9

9.1

—

Nonorganic sleeping disorders, excluding more controls

3.57

1.61

8.2

11.3

—

Diseases of external ear

2.38

1.61

12.2

7.4

—

Single spontaneous delivery

0.00

1.61

0.0

7.6

—

Delivery

0.00

1.60

0.0

7.6

—

Other viral diseases, not elsewhere classified

2.49

1.58

6.6

8.3

—

Falls/tendency to fall

1.71

1.58

12.7

6.3

—

Other viral diseases, not elsewhere classified

2.69

1.57

7.4

9.2

—

Unspecified fall

2.11

1.55

7.1

9.0

—

Sequelae of cerebrovascular disease

2.46

1.54

8.5

11.6

—

Osteoporosis

2.95

1.54

9.2

6.8

—

Excessive attrition of teeth

2.03

1.53

12.5

7.6

—

Other and unspecified effects of external causes

2.43

1.53

6.1

8.5

—

Other respiratory diseases principally affecting the interstitium

3.33

1.52

11.0

8.2

—

Sleep apnoea, including avohilmo

1.76

1.51

9.5

8.3

—

Subjective visual disturbances

2.86

1.50

3.2

8.3

—

Injuries to the elbow and forearm

1.91

1.48

9.5

8.0

—

Degeneration of macula and posterior pole

2.39

1.45

6.1

10.7

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2.54

1.45

11.3

6.4

—

Neurotic, stress-related and somatoform disorders

1.77

1.45

7.5

8.5

—

Diseases of the respiratory system

2.39

1.44

11.7

8.0

—

Visual disturbances

2.12

1.44

6.4

8.3

—

Anxiety (asthma-related co-morbidities)

2.01

1.44

5.7

8.3

—

Suppurative and unspecified otitis media

2.35

1.44

6.9

9.9

—

Adverse effects, not elsewhere classified

3.13

1.44

3.8

7.2

—

Zoster [herpes zoster]

3.13

1.44

5.2

7.2

—

Preterm labour and delivery

3.12

1.43

13.8

5.8

—

2.10

1.41

6.4

8.5

—

Injuries to the shoulder and upper arm

1.77

1.40

11.4

8.0

—

Pulmonary heart disease, diseases of pulmonary circulation

2.41

1.39

4.9

9.0

—

Use of hypnotics and sedatives

1.68

1.37

9.5

8.5

—

Soft tissue disorders

1.69

1.36

7.1

7.4

—

Covid-19 suspected case

2.94

1.36

4.2

7.2

—

Benign neoplasm: Colon

2.06

1.35

7.4

9.7

—

Zoster [herpes zoster]

2.14

1.34

7.0

8.8

—

Periapical abscess

2.13

1.33

10.5

8.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2.18

1.33

10.0

6.9

—

Visual disturbances and blindness

2.04

1.32

6.4

8.2

—

Other disorders of veins

0.00

1.32

0.0

9.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.53

1.31

3.5

5.5

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.53

1.31

3.5

5.5

—

Fracture at wrist and hand level

2.09

1.29

6.4

9.2

—

Shoulder lesions

1.85

1.29

7.9

8.7

—

Other neurological diseases

1.86

1.29

6.6

8.7

—

Anomalies of dental arch relationship, including avohilmo

2.82

1.29

2.4

5.8

—

Artificial joint operation, meniscal resection

0.41

1.28

8.8

9.2

—

Follicular cysts of skin and subcutaneous tissue

2.78

1.28

11.4

9.6

—

Nonorganic sleeping disorders

2.78

1.28

8.2

9.1

—

Other diseases of blood and blood-forming organs, wide

2.78

1.28

3.2

8.8

—

Other viral diseases

2.07

1.25

6.1

8.8

—

Gastro-oesophageal reflux disease

1.83

1.24

11.4

7.8

—

Other disorders of ear

1.68

1.23

6.9

9.4

—

1.86

1.23

8.4

9.2

—

Benign neoplasms

1.67

1.22

6.0

9.7

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2.67

1.21

9.2

8.9

—

Fracture of femur

2.37

1.21

16.5

6.0

—

Later onset COPD

2.66

1.19

12.2

5.9

—

Specific personality disorders

2.31

1.18

4.2

11.0

—

Asthma/COPD (KELA code 203)

1.63

1.18

7.2

8.4

—

Fenamates

0.00

1.18

0.0

4.2

—

Haemorrhoids and perianal venous thrombosis

2.30

1.18

13.0

8.1

—

Other antidepressants

1.63

1.17

6.0

9.1

—

Burns and corrosions

2.50

1.15

8.6

9.3

—

Lyme disease

0.00

1.15

0.0

8.9

—

Other spirochaetal diseases

0.00

1.15

0.0

8.9

—

1.82

1.14

8.4

9.2

—

Spirochaetal infections, other/unspecified

0.00

1.14

0.0

8.8

—

Other spirochaetal diseases

0.00

1.14

0.0

8.8

—

Any mental disorder

1.62

1.13

6.6

8.4

—

Acute suppurative otitis media

2.33

1.12

7.1

9.3

—

Embedded and impacted teeth

2.31

1.11

6.7

8.6

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.03

1.11

10.6

7.1

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2.30

1.11

9.7

7.1

—

Intestinal stricture

2.26

1.10

9.6

8.5

—

Infections with a predominantly sexual mode of transmission

2.26

1.10

17.6

8.5

—

2.42

1.09

6.2

8.4

—

Poisoning by medicine

2.38

1.09

9.8

11.4

—

Fibroblastic disorders

2.38

1.09

8.4

11.0

—

Diseases of male genital organs

1.72

1.07

11.6

7.0

—

Excessive earwax

1.85

1.04

10.5

7.9

—

COPD related to multimorbidity

2.11

1.04

13.1

7.4

—

Poisoning by drugs, medicaments and biological substances

2.27

1.03

9.8

11.0

—

Delivery, wide proxy

0.00

1.03

0.0

7.4

—

Appendectomy

1.73

1.00

11.5

8.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2.00

1.00

8.9

7.7

—

Substance abuse

1.76

0.99

8.9

9.2

—

Ovarian cyst

2.47

0.98

3.2

8.0

—

Other extrapyramidal and movement disorders in other diseases

2.17

0.98

5.0

8.3

—

severe traumatic brain injury, does not include concussion

2.17

0.98

3.4

9.7

—

All anxiety disorders

1.71

0.95

5.7

8.0

—

Mental and behavioural disorders due to psychoactive substance use

1.74

0.95

8.9

9.2

—

Venous thromboembolism

1.77

0.95

5.4

9.2

—

Nerve, nerve root and plexus disorders

1.53

0.94

10.4

8.3

—

Disease of hard tissues of teeth, NOS

2.24

0.93

7.7

8.4

—

Other external causes of accidental injury

1.64

0.92

10.6

5.4

—

Retinal detachments and breaks

2.14

0.91

13.8

11.0

—

Retention of urine

2.14

0.91

11.3

6.2

—

Episodal and paroxysmal disorders

1.49

0.90

11.5

7.4

—

Cystitis

1.66

0.90

7.3

8.0

—

Headache

1.81

0.88

9.6

7.1

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.05

0.88

3.2

6.8

—

Disorders of adult personality and behaviour

2.00

0.87

4.2

10.1

—

Actinic keratosis

1.98

0.86

8.2

8.3

—

Transport accidents

1.81

0.85

14.9

5.5

—

Acute appendicitis, no complications

1.71

0.84

9.4

8.8

—

COPD

1.77

0.83

12.3

9.4

—

Malignant neoplasm of skin

1.77

0.83

10.6

8.5

—

Skin changes due to chronic exposure to nonionizing radiation

1.91

0.83

8.2

8.1

—

Other dorsopathies, not elsewhere classified

1.51

0.82

9.5

8.7

—

1.90

0.82

8.2

8.1

—

Noninflammatory disorders of female genital tract

0.00

0.81

0.0

7.7

—

Artrosis, including avohilmo

0.54

0.81

6.4

8.9

—

Degenerative diseases of the nervous system

0.00

0.81

0.0

7.8

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.70

0.80

12.5

7.5

—

Spinal stenosis

1.69

0.79

5.0

10.2

—

Glaucoma suspect

1.82

0.79

8.2

9.4

—

Alzheimer disease, including avohilmo

0.00

0.79

0.0

7.5

—

Chronic sinusitis

1.67

0.78

4.6

8.2

—

Other strabismus

0.00

0.78

0.0

7.6

—

Other arrhythmias

1.81

0.77

6.7

8.8

—

Obesity related asthma

1.76

0.76

8.8

9.7

—

Conjunctivitis (acute, non atopic)

1.76

0.76

16.8

8.2

—

Injuries to the hip and thigh

1.70

0.75

13.7

7.6

—

Impacted teeth

2.12

0.75

8.2

7.9

—

Atopic dermatitis

1.71

0.75

9.9

7.2

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.69

0.75

6.4

10.2

—

Benign paroxysmal vertigo

2.08

0.74

7.2

9.3

—

Syncope and collapse

1.87

0.74

10.3

7.8

—

COPD, hospital admission 2, with asthma infections

2.04

0.73

9.2

8.3

—

Transient ischemic attack

1.62

0.72

6.0

9.6

—

Glaucoma

1.61

0.72

10.0

9.0

—

Alcohol use disorder, Swedish definition

1.63

0.72

6.0

9.8

—

Injury, poisoning and certain other consequences of external causes

1.73

0.71

4.0

7.5

—

Fracture of forearm

1.59

0.71

12.6

8.0

—

Pregnancy hypertension

1.95

0.71

9.6

7.7

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.74

0.71

19.7

7.8

—

Speech therapy

1.92

0.70

3.8

9.0

—

Intracranial trauma

1.67

0.69

9.5

7.3

—

Dorsopathies

1.44

0.69

8.2

8.6

—

Viral warts

1.85

0.68

6.2

9.4

—

Urticaria

1.85

0.68

3.6

9.2

—

Cholelithiasis

1.54

0.67

6.3

8.9

—

COPD, hospital admissions

1.64

0.67

13.1

8.0

—

Sleep disorders (combined)

1.39

0.66

10.9

7.8

—

Melanocytic naevi

1.72

0.64

6.4

9.3

—

Abrasion of teeth

1.72

0.64

7.0

10.0

—

Symptoms and signs involving the skin and subcutaneous tissue

1.50

0.63

7.8

—

Supervision of high-risk pregnancy

0.00

0.62

0.0

9.0

—

Supervision of normal pregnancy

0.00

0.62

0.0

9.0

—

Antenatal screening

0.00

0.62

0.0

9.0

—

Hallux valgus (acquired)

0.00

0.62

0.0

10.3

—

Female infertility

0.00

0.61

0.0

8.2

—

Special screening examination for infectious and parasitic diseases

0.00

0.61

0.0

7.3

—

Fracture of skull and facial bones

1.67

0.61

7.4

9.3

—

Alzheimer disease

0.00

0.61

0.0

6.9

—

Mouth breathing

1.60

0.61

13.1

8.2

—

Postpartum haemorrhage

0.00

0.61

0.0

4.9

—

Dental pulpitis, including avohilmo

1.41

0.60

12.0

8.2

—

Focal epilepsy, strict definition

0.00

0.60

0.0

7.7

—

Mental and behavioural disorders due to alcohol

1.58

0.60

7.9

9.3

—

Rotator cuff syndrome

1.59

0.59

3.2

8.6

—

Tonsillectomy and adenotomy

1.52

0.59

2.8

8.7

—

Carpal tunnel syndrome

1.57

0.59

8.1

8.8

—

Other degenerative diseases of the nervous system

0.00

0.59

0.0

8.6

—

Other diseases of upper respiratory tract

1.37

0.58

8.2

8.6

—

Hyperplasia of prostate

1.51

0.58

18.4

8.6

—

Focal epilepsy

0.00

0.58

0.0

7.1

—

Necrosis of pulp, including avohilmo

1.52

0.58

9.5

8.4

—

Other anxiety disorders

1.47

0.57

5.4

9.1

—

Fracture of rib(s), sternum and thoracic spine

1.67

0.56

12.5

8.7

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.67

0.56

6.3

9.9

—

Non-selective monoamine reuptake inhibitors

1.65

0.56

9.3

9.2

—

Fall on same level involving ice and snow

1.50

0.54

12.3

8.6

—

Pain in joint

1.47

0.54

9.7

—

Basal cell carcinoma, including avohilmo

1.53

0.52

6.2

7.1

—

Biguanides

1.42

0.51

10.0

9.5

—

Accidents

1.43

0.51

10.3

5.4

—

Other specific joint derangements/joint disorders

1.48

0.49

8.2

7.3

—

Other chronic obstructive pulmonary disease

1.56

0.49

13.1

9.4

—

COPD, early/later onset

1.55

0.49

13.1

8.4

—

Infections with a predominantly sexual mode of transmission

1.55

0.49

17.6

8.6

—

Depression or dysthymia

1.48

0.48

7.7

9.2

—

Low back pain

1.44

0.48

7.8

9.3

—

Cholelithiasis, broad definition with cholecystitis

1.41

0.47

6.3

9.2

—

Recurrent or chronic depression

1.60

0.43

8.2

10.5

—

Outcome of delivery

0.00

0.42

0.0

10.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.58

0.42

8.4

9.7

—

Alzheimer’s disease (Late onset), excluding more controls

0.00

0.42

0.0

9.9

—

Alzheimer disease, excluding more controls

0.00

0.42

0.0

9.9

—

Postmenopausal bleeding

0.00

0.42

0.0

4.6

—

Disorders of refraction and accommodation

1.56

0.42

5.6

8.2

—

Dysplasia of cervi uteri

0.00

0.42

0.0

7.8

—

Single delivery by forceps and vacuum extractor

0.00

0.42

0.0

8.1

—

Postpartum hemorraghe, parous women as controls

0.00

0.41

0.0

8.8

—

Other chronic obstructive pulmonary disease, including avohilmo

1.38

0.41

11.6

8.6

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.43

0.41

10.5

8.0

—

Malignant neoplasm of bronchus and lung, including Hilmo

0.00

0.41

0.0

8.9

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

0.41

0.0

8.9

—

Congenital malformations of cardiac septa

0.00

0.41

0.0

5.5

—

Lichen planus, including avohilmo

0.00

0.41

0.0

8.1

—

Alzheimer’s disease (Late onset)

0.00

0.40

0.0

7.0

—

Alzheimer’s disease, strict definition

0.00

0.40

0.0

7.0

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.40

0.0

7.5

—

Chronic diseases of tonsils and adenoids

1.34

0.39

4.0

8.6

—

Pain in throat and chest

1.41

0.39

4.5

8.1

—

Use of memantine

0.00

0.39

0.0

6.9

—

Use of other anti-dementia drugs

0.00

0.39

0.0

6.9

—

Urolithiasis

1.43

0.39

15.0

7.9

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.39

0.0

8.1

—

Urticaria and erythema

1.39

0.38

3.6

8.2

—

Intracranial injury

1.33

0.37

9.6

7.5

—

Other and unspecified disorders of vitreous body

1.37

0.37

8.2

8.6

—

Disorders of conjunctiva

0.70

0.37

12.9

7.7

—

Malignant neoplasm, wide definition for exclusion

1.31

0.37

6.5

8.2

—

Other disorders of eyelid

1.36

0.37

10.2

8.3

—

Dorsalgia

1.30

0.37

11.1

8.7

—

Lumbar disc prolapse

1.28

0.36

6.0

10.0

—

Liquid cancers, helper endpoint

1.45

0.36

7.8

7.6

—

Asthma, hospital admissions , main diagnosis only

1.30

0.35

7.0

8.5

—

Other arthrosis

1.34

0.34

5.7

8.8

—

DVT of lower extremities and pulmonary embolism

1.33

0.33

6.5

9.6

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.32

0.33

6.2

9.4

—

Disorders of vestibular function (Vertigo)

1.28

0.32

8.7

9.0

—

Solid cancers, helper endpoint

1.29

0.32

8.1

8.5

—

Concussion

1.36

0.31

11.6

7.3

—

Injuries to the head

1.23

0.31

8.8

8.1

—

Organic, including symptomatic, mental disorders

1.31

0.31

8.1

8.3

—

Other intervertebral disc disorders

1.31

0.31

6.0

9.9

—

Alcohol use disorder, ICD-based

1.32

0.30

5.1

10.2

—

Diseases of inner ear

1.25

0.29

12.1

8.4

—

Noninfective enteritis and colitis

1.25

0.29

6.9

8.5

—

Migraine

1.23

0.29

13.6

6.3

—

Congenital malformations, deformations and chromosomal abnormalities

1.30

0.26

5.1

8.1

—

Benzodiazepine use

1.22

0.26

10.4

8.4

—

Injuries to the wrist and hand

1.22

0.25

5.9

8.9

—

Cholecystectomy

1.21

0.25

6.3

8.7

—

Malignant neoplasm

1.24

0.24

6.6

8.2

—

Basal cell carcinoma

1.33

0.23

6.4

7.2

—

Inflammatory bowel disease

1.32

0.23

8.8

9.7

—

Other diseases of lip and oral mucosa

1.28

0.23

4.8

8.8

—

Any event in cancer register

1.21

0.22

6.5

8.2

—

Extrapyramidal and movement disorders

1.22

0.22

5.0

9.6

—

Pregnancy examination and test

0.00

0.21

0.0

9.9

—

Perineal laceration during delivery

0.00

0.21

0.0

3.6

—

Prolonged pregnancy

0.00

0.21

0.0

5.7

—

Parkinson's disease, excluding more controls

0.00

0.21

0.0

9.9

—

Non-small cell lung cancer, including Hilmo

0.00

0.21

0.0

7.3

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.21

0.0

9.9

—

Kela-code for severe mental illness

1.19

0.21

7.0

9.6

—

Medical treatment for female infertility

0.00

0.21

0.0

8.6

—

Foreign body or object entering through skin

0.00

0.21

0.0

7.6

—

Varicose veins of other sites

0.00

0.21

0.0

7.2

—

Contact with other sharp object(s)

0.00

0.21

0.0

7.2

—

Exposure to other and unspecified inanimate mechanical forces

0.00

0.21

0.0

7.1

—

Ankylosing spondylitis, ICD10

0.00

0.21

0.0

7.1

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

0.21

0.0

8.3

—

Ankylosing spondylitis

0.00

0.21

0.0

10.6

—

Other psoriatic arthropathies

0.00

0.21

0.0

4.6

—

Bitten or struck by other mammals

0.00

0.21

0.0

4.4

—

Bell's palsy

0.00

0.21

0.0

10.2

—

Monoamine oxidase A inhibitors

0.00

0.21

0.0

13.1

—

Parkinson's disease, strict definition

0.00

0.21

0.0

5.6

—

Lateral epicondylitis

0.00

0.21

0.0

12.6

—

ILD, hospital admissions

0.00

0.21

0.0

9.0

—

Parkinson's disease

0.00

0.21

0.0

5.6

—

Budesonide

0.00

0.21

0.0

5.9

—

Retinal breaks without detachment

0.00

0.21

0.0

11.6

—

Malignant neoplasm of breast, HER-negative

0.00

0.21

0.0

6.0

—

Malignant neoplasm of breast, ER-negative, including Hilmo

0.00

0.21

0.0

6.0

—

Conjunctivitis

0.78

0.21

12.9

7.6

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.21

0.0

6.7

—

Chalazion

0.00

0.21

0.0

9.0

—

Mucosal proctocolitis

0.00

0.21

0.0

8.5

—

Other interstitial pulmonary diseases

0.00

0.21

0.0

8.4

—

Interstitial lung disease

0.00

0.21

0.0

8.4

—

Interstitial lung disease endpoints

0.00

0.21

0.0

8.4

—

Spondylopathies (FG)

0.00

0.21

0.0

10.5

—

Parkinson's disease, including avohilmo

0.00

0.21

0.0

5.8

—

Dentofacial anomalies [including malocclusion]

1.24

0.21

9.4

8.4

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.21

0.0

5.4

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.21

0.0

7.9

—

Use of disulfiram, acamprosate or naltrexone

0.00

0.21

0.0

9.0

—

Psoriatic arthropathies, ICD10

0.00

0.21

0.0

8.5

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

0.21

0.0

8.0

—

Other disorders of conjunctiva

0.00

0.21

0.0

5.7

—

Persistent mood disorders

0.00

0.21

0.0

11.5

—

Postpartum hemorraghe, all women as controls

0.00

0.20

0.0

10.0

—

Septal defects

0.00

0.20

0.0

3.5

—

Insomnia

0.79

0.20

7.4

8.5

—

Malignant neoplasm of bronchus and lung

0.00

0.20

0.0

6.7

—

Sleep disorders

0.77

0.20

7.4

8.5

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.20

0.18

7.3

8.3

—

Selective serotonin reuptake inhibitors

0.83

0.17

7.4

8.8

—

Dislocation, sprain and strain of joints and ligaments of knee

0.72

0.17

16.6

7.7

—

Exclusions for E4_PCOS_CONSORTIUM

1.10

0.15

6.3

7.5

—

Caries of enamel

1.16

0.15

3.9

8.8

—

Mycoses

1.15

0.13

8.1

8.4

—

Disorders of eyelid, lacrimal system and orbit

0.83

0.13

7.9

8.8

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.14

0.11

10.0

8.5

—

Leiomyoma of uterus

1.13

0.10

6.6

8.1

—

Unspecified mental disorder

1.14

0.10

7.0

9.3

—

Coxarthrosis [arthrosis of hip](FG)

1.10

0.10

10.0

9.7

—

Congenital malformations, deformations and chromosomal abnormalities

1.15

0.09

5.1

7.8

—

Meniscus derangement

1.05

0.09

6.4

9.3

—

Other symptoms and signs involving cognitive functions and awareness

1.06

0.09

4.8

8.5

—

Procreative management

0.82

0.08

10.4

7.7

—

Varicose veins

0.79

0.08

4.6

9.7

—

Coxarthrosis, primary

0.81

0.08

10.0

8.8

—

Asthma, including avohilmo

1.08

0.05

6.4

8.6

—

Other joint disorders

1.08

0.01

7.0

7.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.05

0.01

4.9

9.5

—

Lower back pain or/and sciatica

1.03

0.00

6.9

9.1

—

Asthma (diagnoses ohter than nonallergic)

1.02

0.00

5.8

8.7

—

Behavioural syndromes associated with physiological disturbances and physical factors

0.97

0.00

7.5

8.4

—

Other congenital malformations of skin

0.00

0.0

7.4

—

Injury of muscle and tendon at hip and thigh level

0.00

0.0

8.3

—

ILD, hospital admissions 1, main diag only

0.00

0.0

10.6

—

Benign neoplasm of middle ear and respiratory system

0.00

0.0

9.3

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

0.85

0.00

11.8

8.6

—

Recurrent dislocation and subluxation of joint

0.00

0.0

10.6

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.0

9.0

—

Left ventricular outflow tract obstruction, narrow definition

0.00

0.0

3.9

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.0

5.6

—

Emotional disorders and disorders of social functioning with onset specific to childhood

0.00

0.0

2.0

—

Generalized epilepsy

0.00

0.0

4.5

—

Divergent concomitant strabismus

0.00

0.0

5.0

—

Atrophic disorders of skin

0.00

0.0

3.4

—

Pneumonia due to other infectious organisms, not elsewhere classified

0.00

0.0

5.6

—

Colon adenocarcinoma

0.00

0.0

5.3

—

Pleural plaque

0.00

0.0

6.4

—

Other disorders of amniotic fluid and membranes

0.00

0.0

6.5

—

Residual foreign body in soft tissue

0.00

0.0

9.2

—

Other and unspecified intracranial injuries

0.00

-0.00

0.0

5.4

—

Congenital malformations of aortic and mitral valves

0.00

-0.00

0.0

4.7

—

Event of undetermined intent

0.00

-0.00

0.0

8.3

—

Other appendicitis

0.00

-0.00

0.0

8.1

—

Helminthiases

0.00

-0.00

0.0

5.8

—

Other benign neoplasms of connective and other soft tissue

0.00

-0.00

0.0

10.3

—

L04AC Interleukin inhibitors

0.00

-0.00

0.0

6.0

—

ILD, hospital admissions 3, with pneumonia sepsis

0.00

-0.00

0.0

9.6

—

Crohn's disease of small intestine

0.00

-0.00

0.0

5.4

—

Other female pelvic inflammatory diseases

0.00

-0.00

0.0

5.2

—

Lung cancer and mesothelioma

0.00

-0.00

0.0

7.7

—

Patent foramen ovale

0.00

-0.00

0.0

2.2

—

Flat foot [pes planus] (acquired)

0.00

-0.00

0.0

3.0

—

Traumatic amputation of wrist and hand

0.00

-0.00

0.0

2.2

—

ILD, hospital admission 2, with pulmonary infections

0.00

-0.00

0.0

9.4

—

Lichen planus

0.00

-0.00

0.0

5.3

—

Abnormal weight loss

0.00

-0.00

0.0

4.5

—

Malignant neoplasm of corpus uteri

0.00

-0.00

0.0

4.4

—

Heterophoria

0.00

-0.00

0.0

4.2

—

Wide developmental disorders

0.00

-0.00

0.0

2.2

—

Atrial septal defect

0.00

-0.00

0.0

2.9

—

Spirochaetal infections, other/unspecified

0.00

-0.00

0.0

5.0

—

L02BB Anti-androgens

0.00

-0.00

0.0

6.0

—

Arthrosis

0.94

-0.00

7.2

8.7

—

Emotional disorders starting during childhood or adolescence

0.00

-0.00

0.0

2.1

—

Infectious mononucleosis

0.00

-0.00

0.0

3.7

—

Systemic atrophies primarily affecting the central nervous system

0.00

-0.00

0.0

4.8

—

Caught, crushed, jammed or pinched in or between objects

0.00

-0.00

0.0

5.2

—

Scoliosis

0.00

-0.00

0.0

2.2

—

Alzheimer’s disease (Atypical or mixed)

0.00

-0.00

0.0

4.7

—

Pneumonia due to Streptococcus pneumoniae

0.00

-0.00

0.0

5.6

—

Mental disorders, not otherwise specified

0.00

-0.00

0.0

7.6

—

Adalimumab

0.00

-0.00

0.0

8.3

—

Cysts of oral region, not elsewhere classified

0.00

-0.00

0.0

5.2

—

Dizziness and giddiness

0.99

-0.00

12.0

8.0

—

Hydrocephalus

0.00

-0.00

0.0

5.8

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

0.00

-0.00

0.0

5.2

—

Noise effects on inner ear

0.00

-0.00

0.0

4.2

—

Schizoaffective disorder

0.00

-0.00

0.0

8.3

—

Other symptoms and signs involving general sensations and perceptions

0.00

-0.00

0.0

5.4

—

Glaucoma, exfoliation

0.00

-0.00

0.0

8.2

—

Other otitis externa (chronic)

0.00

-0.00

0.0

5.6

—

Sequelae of infectious and parasitic diseases

0.00

-0.00

0.0

10.2

—

Otalgia

0.00

-0.00

0.0

5.2

—

Intermittent heterotropia

0.00

-0.00

0.0

4.0

—

Crohn disease (strict definition, all UC cases excluded)

0.00

-0.00

0.0

5.4

—

Benign neoplasm of meninges

0.00

-0.00

0.0

6.2

—

Convergent concomitant strabismus

0.00

-0.00

0.0

5.6

—

Barrett oesophagus

0.00

-0.00

0.0

6.4

—

Sequelae of injuries of head

0.00

-0.00

0.0

3.5

—

Fracture of neck

0.00

-0.00

0.0

5.6

—

Benign neoplasm: Caecum

0.00

-0.00

0.0

7.5

—

Contact with nonpowered hand tool

0.00

-0.00

0.0

10.7

—

Speech disturbances, not elsewhere classified

0.00

-0.00

0.0

5.6

—

Vestibular neuronitis

0.00

-0.00

0.0

5.2

—

Mental and behavioural disorders due to opioids

0.00

-0.00

0.0

8.6

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.00

-0.00

0.0

2.6

—

Malignant neoplasm of bladder, including Hilmo

0.00

-0.00

0.0

10.5

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.00

-0.00

0.0

10.4

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

-0.00

0.0

8.3

—

Pneumothorax

0.00

-0.00

0.0

7.1

—

Other and unspecified mood [affective] disorders

0.00

-0.00

0.0

4.6

—

Dermatophytosis

0.90

-0.00

4.3

8.9

—

Psoriatic arthropathies

0.00

-0.00

0.0

14.1

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

-0.00

0.0

8.6

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

8.1

—

Endometriosis of rectovaginal septum and vagina

0.00

-0.00

0.0

3.5

—

conjunctival haemorrhage

0.00

-0.00

0.0

5.0

—

Drug-induced neutropenia

0.00

-0.00

0.0

5.6

—

Ulcerative proctitis

0.00

-0.00

0.0

5.4

—

Idiopathic pulmonary fibrosis

0.00

-0.00

0.0

9.6

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

-0.00

0.0

9.0

—

Psoriatic and enteropathic arthropathies

0.00

-0.00

0.0

12.9

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

-0.00

0.0

6.8

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

8.7

—

Benign mammary dysplasia

0.00

-0.00

0.0

4.4

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

-0.00

0.0

5.2

—

Endometriosis of pelvic peritoneum

0.00

-0.00

0.0

6.3

—

Unspecified lump in breast

0.00

-0.00

0.0

5.4

—

Pain associated with micturition

0.00

-0.00

0.0

6.0

—

Malignant melanoma of skin

0.00

-0.00

0.0

11.1

—

Hyperkinetic disorders (excl. ADHD)

0.00

-0.00

0.0

2.4

—

Alcohol-induced acute pancreatitis

0.00

-0.00

0.0

5.8

—

Cervicocranial syndrome

0.00

-0.00

0.0

6.0

—

Other disorders of the genitourinary system

0.00

-0.00

0.0

5.7

—

Use of rivastigmine

0.00

-0.00

0.0

6.1

—

Desensitization to allergens

0.00

-0.00

0.0

2.2

—

Pedestrian injured in transport accident

0.00

-0.00

0.0

4.7

—

Open wound of head

0.96

-0.00

7.3

8.2

—

Weight loss

0.00

-0.00

0.0

6.8

—

Struck by thrown, projected or falling objec

0.00

-0.00

0.0

7.3

—

Multiple delivery

0.00

-0.00

0.0

9.6

—

Malignant neoplasm of corpus uteri, including Hilmo

0.00

-0.00

0.0

4.0

—

Malignant neoplasm of bladder

0.00

-0.00

0.0

6.2

—

Chromosomal abnormalities, not elsewhere classified

0.00

-0.00

0.0

1.8

—

Pleural plaque with presence of asbestos

0.00

-0.00

0.0

7.0

—

Polypectomy (DHB20)

0.00

-0.00

0.0

9.9

—

Other noninflammatory disorders of vulva and perineum

0.00

-0.00

0.0

3.8

—

Dementia in Alzheimer disease

0.00

-0.00

0.0

6.9

—

Non-small cell lung cancer

0.00

-0.00

0.0

6.2

—

Congenital malformations of eye, ear, face and neck

0.00

-0.00

0.0

5.0

—

Spondylopathies

1.01

-0.00

8.2

9.3

—

Ankylosing spondylitis, strict definition

0.00

-0.00

0.0

11.2

—

Trochanteric bursitis

0.00

-0.00

0.0

7.8

—

Use of biperiden

0.00

-0.00

0.0

5.8

—

Raynaud syndrome

0.00

-0.00

0.0

5.6

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

-0.00

0.0

4.2

—

Benign neoplasm of bone and articular cartilage

0.00

-0.00

0.0

4.0

—

Hypogonadotropic hypogonadism

0.00

-0.00

0.0

8.8

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS